| Literature DB >> 33230005 |
Hantao Zhang1, Irene Lecker1, Chereen Collymore2,3, Anastassia Dokova4, Maian Christine Pham1, Sarah F Rosen4, Hayley Crawhall-Duk4, Maham Zain1, Megan Valencia1, Helena Fetter Filippini1, Jerry Li1, Abigail J D'Souza1,5, Chulmin Cho6, Vassilia Michailidis6, Paul D Whissell7, Ingita Patel1, Hendrik W Steenland8, Wai-Jane Virginia Lee9, Massieh Moayedi9, Toni-Lee Sterley10, Jaideep S Bains10, Jo Anne Stratton11,12, John R Matyas12, Jeff Biernaskie10,12, David Dubins1, Igor Vukobradovic5, Alexandr Bezginov5, Ann M Flenniken5, Loren J Martin6,7, Jeffrey S Mogil4, Robert P Bonin1,7,13.
Abstract
ABSTRACT: The development of new analgesic drugs has been hampered by the inability to translate preclinical findings to humans. This failure is due in part to the weak connection between commonly used pain outcome measures in rodents and the clinical symptoms of chronic pain. Most rodent studies rely on the use of experimenter-evoked measures of pain and assess behavior under ethologically unnatural conditions, which limits the translational potential of preclinical research. Here, we addressed this problem by conducting an unbiased, prospective study of behavioral changes in mice within a natural homecage environment using conventional preclinical pain assays. Unexpectedly, we observed that cage-lid hanging, a species-specific elective behavior, was the only homecage behavior reliably impacted by pain assays. Noxious stimuli reduced hanging behavior in an intensity-dependent manner, and the reduction in hanging could be restored by analgesics. Finally, we developed an automated approach to assess hanging behavior. Collectively, our results indicate that the depression of hanging behavior is a novel, ethologically valid, and translationally relevant pain outcome measure in mice that could facilitate the study of pain and analgesic development.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33230005 PMCID: PMC8054539 DOI: 10.1097/j.pain.0000000000002127
Source DB: PubMed Journal: Pain ISSN: 0304-3959 Impact factor: 7.926
Figure 1.Hanging behavior is impaired in models of inflammatory and neuropathic pain. (A) The effect of injection of complete Freund's adjuvant (CFA) or spared nerve injury (SNI) on 8 distinct homecage behaviors of CD-1 mice was quantified using automated video scoring (CleverSys HomeCageScan). Data are shown as the percentage of time mice participated in each behavior over 24 hours (average ± SEM). Note that hanging behavior is reduced after both CFA and SNI, but only recovers to normal levels after CFA, not after SNI. *P < 0.05, **P < 0.01, ***P < 0.001 compared with baseline (−1).
Figure 2.Impairments in hanging behavior are noxious stimulus intensity-dependent and reversed by analgesics. (A) The effect of nociceptive assays targeting the plantar region or systemic circulation on hanging behavior of C57BL/6N mice. Values represent time hanging after different assays normalized to control (saline injection or sham surgery as appropriate); intraplantar formalin (1% in 10 µL); intraplantar capsaicin (0.5% in 5 µL); osteoarthritis induced by ACL transection; spared nerve injury (SNI); intraplantar CFA; lipopolysaccharide (LPS, 15 µg/kg); and cyclophosphamide (CYP, 100 mg/kg). Dose-dependent reductions in hanging behavior were observed after i.p. injection of (B) CYP (30, 100, and 300 mg/kg) and (C) LPS (1.5, 15, and 150 μg/kg). (D) Intraplantar injection of formalin (1%, 10 μL) induced nocifensive licking and biting behavior in C57BL/6N mice. The total amount of time spent licking or biting 45 minutes after injection was inversely correlated with the amount of time mice participated in hanging behavior (r = −0.44, P = 0.05). (E) Dose-dependent effect of gabapentin (10, 30, and 100 mg/kg, i.p., n = 9, crossover design) on hanging behavior or mechanical paw withdrawal threshold (PWT) assessed using the SUDO assay with von Frey filaments one week after SNI. Data are shown normalized to presurgery values. (F) The amount of time mice spent hanging and paw PWT relative to presurgical levels for all mice in graph E were correlated such that decreased time hanging was associated with lower PWT after SNI (n = 36, r = 0.39, P =0.02). (G–I) Analgesics reversed the reduction of hanging behavior seen in different pain models. (G) The effect of formalin (1%, 10 μL, intraplantar) on hanging was reversed with either ketoprofen (5 mg/kg, i.p.), tramadol (30 mg/kg, i.p.), or gabapentin (100 mg/kg), but not reversed with U50,488H (10 mg/kg, i.p.). (H) The effect of CYP (100 mg/kg, i.p.) on hanging was reversed by ketoprofen (5 mg/kg, i.p.) and tramadol (30 mg/kg, i.p.) but not gabapentin (100 mg/kg, i.p.). (I) The effect of LPS (15 µg/kg, i.p.) was reversed by ketoprofen (5 mg/kg, i.p.). Data represented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 compared with noxious stimulus group. CFA, complete Freund's adjuvant; ACL, anterior cruciate ligament.
Figure 3.Hanging behavior is dependent on circadian and physiological factors of age, sex, and strain. (A) Hanging behavior in 1- to 6-month-old male (n = 8) and (B) female (n = 8) C57BL/6N mice over a 24-hour period. Peak hanging periods occurred upon introduction of mouse to the testing cage and during the dark phase. (C) Hanging behavior of male (n = 8) and (D) female (n = 8) C57BL/6N mice expressed as total percentage of time of a 24-hr period at different ages. Two-month-old mice show significantly higher hanging behavior than older and younger mice in both males and females. (E) The effect of sex and strain on hanging behavior. C57BL/6N mice (n = 26 male, 26 female) showed significantly more hanging behavior than CD-1 mice (n = 17 male, 17 female). Female mice showed more hanging than age-matched male mice regardless of strain. (F) Hanging behavior of 2-month-old naive male C57BL/6N mice (n = 64) did not correlate with the weight of mice. Data represented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 as indicated.
Figure 4.Hanging behavior can by isolated as a measure of pain using a dedicated hanging environment and automated detection strategies. (A) Hanging behavior was assessed using a normal homecage and a dedicated hanging assay comprised of a small box with an angled metal grid (HangBox). Male C57BL/6N mice spent significantly more time engaged in hanging in the HangBox (n = 24) compared with the homecage (n = 36). (B) Lid contact in the HangBox was detected using a capacitance sensing device for automatic assessment of hanging behavior. Automated detection of the amount of time mice were in contact with the metal lid through capacitance detection strongly correlated with amount of time mice were engaged in hanging as assessed by video scoring (r = 0.90, n = 24). (C) The effect of cyclophosphamide (CYP) on hanging behavior of male C57BL/6N mice in the HangBox measured by both EthoVision and the capacitance sensing device. CYP (n = 12) decreased hanging in the HangBox assay compared with saline injected mice (n = 12) when hanging behavior was assessed by either video (EthoVision) or capacitance sensing. (D) Intraplantar CFA (n = 35) significantly reduced cage lid interaction frequency as measured by capacitance sensing one day after injection (compared with baseline). Data represented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 compared with saline/baseline. CFA, complete Freund's adjuvant.